The information you need to start a radiation dose safety program as presented at AHRA 2014.
WASHINGTON, D.C.-“Step into the spotlight before the spotlight finds you,” Shawn McKenzie of Ascendian Healthcare Consulting, said at AHRA 2014. And a summation for dose management as dictated to the imaging administrators at AHRA was established.It’s a tough sell. Healthcare is an industry already lagging behind in innovative efforts. And as McKenzie and Neomi Mullens, also of Ascendian, mentioned, the spotlight might be shining, but not necessarily on you, yet. “Yet” being the operative word. Â Dose has been a hot topic at AHRA, as both vendors and organizations are diving into the dose management initiative and figuring out how it is best navigated. The “Radiation Dose Safety: Defining and Implementing an Enterprise Dose Management Program” session was aimed at this initiative, and educating managers about how to implement this significant and looming process. Check out the slideshow to see what you need to know about establishing a program.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.